PLUS THERAPEUTICS, INC.
Ticker: 1095981
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 0.41-60.2% | 1.03-26.4% | 1.40+0.7% | 1.39+31.1% | 1.06 |
| Total Income | 0.41-60.2% | 1.03-26.4% | 1.40+0.7% | 1.39+31.1% | 1.06 |
| EXPENSES | |||||
| Expenditure | 9.47+16.2% | 8.15+38.6% | 5.88+100.7% | 2.93-36.3% | 4.60 |
| PROFIT | |||||
| Net Profit | -9.01-29.6% | -6.95-57.2% | -4.42-185.8% | 5.15+129.6% | -17.40 |
| KEY METRICS | |||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00%-200.00pp | 100.00%+200.00pp | -100.00% |
| EPS | -1.31-24.8% | -1.05-2525.0% | -0.04-300.0% | 0.02+101.7% | -1.19 |
Corporate Events
Board MeetingPSTV
202614May
Board Meeting
Results of the 2026 Annual Meeting of Stockholders, includin…
SEC Filing ↗ Board MeetingPSTV
202620Apr
Board Meeting
Executive Appointment — Eric J. Daniels, M.D., M.B.A. appoin…
SEC Filing ↗